Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Summaries of opinion Remove Summaries of opinion filter Referrals Remove Referrals filter

Product number

Date of opinion

From:

To:

Referral name

Referral status

European Commission final decision Remove European Commission final decision filter Opinion provided by Committee for Medicinal Products for Human Use Remove Opinion provided by Committee for Medicinal Products for Human Use filter Procedure started (1) Apply Procedure started filter

Referral safety status

Yes (1) Apply Yes filter

Referral type

Article 20 procedures Remove Article 20 procedures filter Article 6(12) referrals (prior to January 2010) Remove Article 6(12) referrals (prior to January 2010) filter Article 29(4) referrals Remove Article 29(4) referrals filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (1) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally authorised product(s) (2) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (1) Apply Risk minimisation measures filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Decision date

From:

To:

Medicine type

Accelerated assessment Remove Accelerated assessment filter Additional monitoring (11) Apply Additional monitoring filter Conditional approval (1) Apply Conditional approval filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

2 results

Remove all filtersRemove all filters

Categories Human Remove Human filter

Medicine Summaries of opinion Remove Summaries of opinion filter Referrals Remove Referrals filter

Referral status European Commission final decision Remove European Commission final decision filter Opinion provided by Committee for Medicinal Products for Human Use Remove Opinion provided by Committee for Medicinal Products for Human Use filter

Referral type Article 20 procedures Remove Article 20 procedures filter Article 29(4) referrals Remove Article 29(4) referrals filter Article 6(12) referrals (prior to January 2010) Remove Article 6(12) referrals (prior to January 2010) filter

Medicine type Accelerated assessment Remove Accelerated assessment filter

Sort by

List item

Referral: Lartruvo

olaratumab, associated names: Lartruvo, Article 20 procedures
Status: European Commission final decision, opinion/position date: 31/01/2019, EC decision date: 19/07/2019, Last updated: 22/08/2019
List item

Referral: Direct-acting antivirals indicated for treatment of hepatitis C (interferon-free)

daclatasvir, dasabuvir, sofosbuvir, ledipasvir, simeprevir, ombitasvir, paritaprevir, ritonavir, associated names: Sovaldi, Olysio, Viekirax, Harvoni, Exviera, Daklinza, Article 20 procedures
Status: European Commission final decision, opinion/position date: 15/12/2016, EC decision date: 23/02/2017, Last updated: 09/03/2017

2 results

Referral: Lartruvo

Referral: Direct-acting antivirals indicated for treatment of hepatitis C (interferon-free)